Evan L. Gilius
National Cancer Institute(US)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Pancreatic and Hepatic Oncology Research, Lung Cancer Research Studies, Peptidase Inhibition and Analysis, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice(2014)46 cited
- → Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat(2014)37 cited
- → PhotoImmunoNanoTherapy Reveals an Anticancer Role for Sphingosine Kinase 2 and Dihydrosphingosine-1-Phosphate(2013)34 cited
- → Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis(2012)31 cited
- → A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer(2012)19 cited
- → Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer(2016)5 cited
- → Blockade of the CCK receptor inhibits progression of early PanIN lesions to pancreatic cancer in the Pdx1-Cre, LSL/KrasG12D mouse(2013)2 cited
- → Mo1215 A CCK-a Antagonist Decreases Pancreatic Cancer Metastases in Mice on High Fat Diet(2012)